Articles · Medicine Compliance Aid Stability · Lactation Safety Information ·


Drug-induced hypersalivation – what treatment options are available?

This Medicines Q&A summarises published studies or case reports concerning the pharmacological treatment of drug-induced hypersalivation (drooling or sialorrhoea), particularly hypersalivation caused by clozapine. Update… Amisulpride Atropine Benzatropine Biperiden Botulinum A toxin Bupropion Clonidine Clozapine Glycopyrronium Guanfacine Hyoscine butylbromide Hyoscine hydrobromide Ipratropium Lofexidine Metoclopramide Moclobemide Oxybutynin Pirenzepine Propantheline Q&A Quetiapine Sulpiride Trihexyphenidyl

Medicine Compliance Aid Stability

Zyban · GlaxoSmithKline UK

GlaxoSmithKline UK
Tablets m/r f/c 150mg
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Store in tight, light-resistant containers.
3rd March 2015

Lactation Safety Information


Small amounts in breast milk
2 case reports of seizures in breastfed infants possibly due to bupropion
18th September 2020